Fig. 3From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisa \(\hat{AN}_{AE}(t)\) calculated for different sample sizes; b \(\hat{KM}_{AE}(t)\) calculated for different sample sizesBack to article page